Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spherix Global Insights
Marketing
Novo's Wegovy in line for a 'swift' adoption in MASH: Spherix
Wegovy's mechanism of action could be ideal for patients with more moderate disease, according to gastroenterologists and hepatologists.
Zoey Becker
Aug 29, 2025 11:40am
AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis
Oct 7, 2024 10:53am
Docs discuss ongoing Humira use, name preferred biosimilars
Sep 24, 2024 7:20am
Off-label drugs fall out of favor in lupus
Jun 16, 2023 10:16am
Eisai's Leqembi gaining ground with US neurologists
Apr 11, 2023 10:00am
Docs 'cautious' about GSK's new anemia drug: survey
Feb 9, 2023 2:52pm
